The Damon Runyon Cancer Research Foundation has named six new Damon Runyon Clinical Investigators.
Merck is a new year outlier with its diabetes drug
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech